Compass Therapeutics, Inc. (CMPX) vs ProQR Therapeutics N.V. (PRQR)

A side-by-side comparison of Compass Therapeutics, Inc. and ProQR Therapeutics N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CMPX vs PRQR

growth of $100 · dividends reinvested · last 6y
CMPX -88.7% (-30.5%/yr)PRQR -74.7% (-20.5%/yr)PRQR compounded faster over this window
050100Start $10020222023202420252026$11$25
CMPX PRQR

CMPX vs PRQR: by the numbers

  • •CMPX is the larger company ($175M vs $174M market cap).
  • •Both run net losses; CMPX's is the smaller (0.00% vs -229.20% net margin).

Metrics side by side

Valuation

MetricCMPXPRQR
P/S ratioN/A8.09
P/B ratio1.061.91

Profitability

MetricCMPXPRQR
Gross margin0.00%83.01%
Operating margin0.00%-275.91%
Net margin0.00%-229.20%
ROE-44.23%-54.27%
ROIC-46.59%-42.61%

Growth (annualized)

MetricCMPXPRQR
Revenue CAGR (5Y)N/A94.34%
Total return CAGR (5Y)-22.79%-26.23%

Frequently asked

How have CMPX and PRQR total returns compared?
Over the past 5 years, CMPX delivered -22.79% and PRQR delivered -26.23% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.